Ulrika WARPMAN BERGLUND
Company: Oxcia
Job title: CEO
Seminars:
Harnessing Oxidative Stress & DNA Damage Response Pathways for Innovative Antifibrotic Therapies 2:00 pm
Exploring the role of the enzyme OGG1 in excision repair and cellular reprogramming in inflammatory and fibrotic diseases, and detailing the promise of OGG1 inhibitors to halt inflammation and fibrosis Examining the potential of OXC-201 to offer curative solutions rather than merely symptomatic reliefRead more
day: Day Two